Meixiao Zhan
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Cancer Research top 5%
- Oncology top 10%
- Biomaterials top 5%
- Co-authors
- Ligong LuWei ZhaoXianglong HuXu HeYongjie XinSiyu LuZhixiong WangShaojun Peng
- Topics
- Nanoplatforms for cancer theranostics (28 papers)Cancer Immunotherapy and Biomarkers (12 papers)Hepatocellular Carcinoma Treatment and Prognosis (12 papers)
- Journals
- Proceedings of the National Academy of SciencesAngewandte Chemie International EditionNature Communications
- Partner nations
- ChinaUnited StatesLebanon
In The Last Decade
Meixiao Zhan
112 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 134
- Molecular Biology 1.2k
- Biomedical Engineering 852
- Cancer Research 625
- Oncology 396
- Biomaterials 380
Countries citing papers authored by Meixiao Zhan
This map shows the geographic impact of Meixiao Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixiao Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixiao Zhan more than expected).
Fields of papers citing papers by Meixiao Zhan
This network shows the impact of papers produced by Meixiao Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixiao Zhan. The network helps show where Meixiao Zhan may publish in the future.
Co-authorship network of co-authors of Meixiao Zhan
This figure shows the co-authorship network connecting the top 25 collaborators of Meixiao Zhan. A scholar is included among the top collaborators of Meixiao Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixiao Zhan. Meixiao Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 57 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 30 | |
| 6 | 87 | |
| 7 | 71 | |
| 8 | 56 | |
| 9 | 12 | |
| 10 | 35 | |
| 11 | 27 | |
| 12 | 15 | |
| 13 | Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma | 1 |
| 14 | 26 | |
| 15 | 11 | |
| 16 | 72 | |
| 17 | Camellia nitidissima Chi Extract Potentiates the Sensitivity of Gastric Cancer Cells to Paclitaxel via the Induction of Autophagy and Apoptosis | 1 |
| 18 | 13 | |
| 19 | 62 | |
| 20 | 15 |
About Meixiao Zhan
Meixiao Zhan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 115 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (28 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). The work is most often cited by research in Cancer Research (625 citations), Biomaterials (380 citations) and Hepatology (159 citations). Meixiao Zhan has collaborated with scholars based in China, United States and Lebanon. Frequent co-authors include Ligong Lu, Wei Zhao, Xianglong Hu, Xu He, Yongjie Xin, Siyu Lu, Zhixiong Wang, Shaojun Peng, Shengtao Yuan and Yanhong Su. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.